Avelumab With Chemoradiation in Locally Advanced Rectal Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Rectal Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: All participants will receive standard LCCRT treatment followed by 4 cycles of Avelumab followed by surgical resectionMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03299660
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Michael Michael, A/Prof Peter MacCallum Cancer Centre, Australia